These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8395822

  • 1. Calyculin A inhibits the exposure of fibrinogen receptor in thrombin-stimulated platelets.
    Sakon M, Murata K, Fujitani K, Yano Y, Kambayashi J, Uemura Y, Kawasaki T, Shiba E, Mori T.
    Biochem Biophys Res Commun; 1993 Aug 31; 195(1):139-43. PubMed ID: 8395822
    [Abstract] [Full Text] [Related]

  • 2. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
    Murata K, Sakon M, Kambayashi J, Yukawa M, Ariyoshi H, Shiba E, Kawasaki T, Kang J, Mori T.
    Biochem Int; 1992 Feb 31; 26(2):327-34. PubMed ID: 1313673
    [Abstract] [Full Text] [Related]

  • 3. Aggregation-dependent signaling in human platelets is sensitive to protein serine/threonine phosphatase inhibitors.
    Hoyt CH, Lerea KM.
    Biochemistry; 1995 Jul 25; 34(29):9565-70. PubMed ID: 7626626
    [Abstract] [Full Text] [Related]

  • 4. The possible involvement of protein phosphatase 1 in thrombin-induced Ca2+ influx of human platelets.
    Murata K, Sakon M, Kambayashi J, Yukawa M, Yano Y, Fujitani K, Kawasaki T, Shiba E, Mori T.
    J Cell Biochem; 1993 Apr 25; 51(4):442-5. PubMed ID: 8388395
    [Abstract] [Full Text] [Related]

  • 5. Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A.
    Yano Y, Sakon M, Kambayashi J, Kawasaki T, Senda T, Tanaka K, Yamada F, Shibata N.
    Biochem J; 1995 Apr 15; 307 ( Pt 2)(Pt 2):439-49. PubMed ID: 7733881
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
    Lerea KM.
    Biochemistry; 1992 Jul 21; 31(28):6553-61. PubMed ID: 1321663
    [Abstract] [Full Text] [Related]

  • 7. Endogenous platelet fibrinogen surface expression on activated platelets.
    Gralnick HR, Williams S, McKeown L, Connaghan G, Shafer B, Hansmann K, Vail M, Fenton J.
    J Lab Clin Med; 1991 Dec 21; 118(6):604-13. PubMed ID: 1744509
    [Abstract] [Full Text] [Related]

  • 8. Differences between platelet and microparticle glycoprotein IIb/IIIa.
    Nomura S, Suzuki M, Kido H, Yamaguchi K, Fukuroi T, Yanabu M, Soga T, Nagata H, Kokawa T, Yasunaga K.
    Cytometry; 1992 Dec 21; 13(6):621-9. PubMed ID: 1451594
    [Abstract] [Full Text] [Related]

  • 9. Platelet talin is phosphorylated by calyculin A.
    Murata K, Sakon M, Kambayashi J, Okuyama M, Hase T, Mori T.
    J Cell Biochem; 1995 Jan 21; 57(1):120-6. PubMed ID: 7721951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS.
    J Clin Invest; 1985 Jul 21; 76(1):101-8. PubMed ID: 2991335
    [Abstract] [Full Text] [Related]

  • 14. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF, Sheu JR, Teng CM, Chen SW, Liu CS.
    J Biochem; 1991 Feb 21; 109(2):328-34. PubMed ID: 1864844
    [Abstract] [Full Text] [Related]

  • 15. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
    Goad DL, Meurer EA, Voelkel EF, Petrou CP, Tashjian AH.
    Endocrinology; 1992 Jun 21; 130(6):3402-10. PubMed ID: 1375901
    [Abstract] [Full Text] [Related]

  • 16. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
    Frojmovic MM, Mooney RF, Wong T.
    Biophys J; 1994 Nov 21; 67(5):2060-8. PubMed ID: 7858143
    [Abstract] [Full Text] [Related]

  • 17. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM, Mooney RF, Wong T.
    Biophys J; 1994 Nov 21; 67(5):2069-75. PubMed ID: 7858144
    [Abstract] [Full Text] [Related]

  • 18. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT, Hodson E, Roberts JR, Kunicki TJ, Zimmerman TS, Ruggeri ZM.
    J Clin Invest; 1985 Nov 21; 76(5):1950-8. PubMed ID: 2414325
    [Abstract] [Full Text] [Related]

  • 19. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY, Wu YC, Wu CC.
    Mol Pharmacol; 2006 Oct 21; 70(4):1380-9. PubMed ID: 16837624
    [Abstract] [Full Text] [Related]

  • 20. Ligand interactions with the RGD recognition site alter binding of GPIIb-IIIa reactive monoclonal antibody to human platelets.
    Marder P.
    Biochem Biophys Res Commun; 1993 Sep 15; 195(2):799-806. PubMed ID: 8373415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.